Zobrazeno 1 - 10
of 297
pro vyhledávání: '"nanoparticle albumin‐bound"'
Autor:
Lina Yin, Wei Jiang, Shuai Liu, Yi Fu, Lin Zhou, Xuan Pei, Shuang Ye, Wenbin Shen, Huijuan Yang, Boer Shan
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Neoadjuvant chemotherapy may be considered for patients with ovarian cancer (OC) whose tumors are deemed unlikely to be completely cytoreduced to no gross residual disease (R0) or who are poor surgical candidates. This Ib/II study
Externí odkaz:
https://doaj.org/article/b1f4c536d6d54eba85e05685b2d3d915
Publikováno v:
Nano TransMed, Vol 3, Iss , Pp 100036- (2024)
Background: Due to the rapid development of nanotechnology and nanocomplex synthetic techniques, a large number of nanoparticle-based cancer medicines have been evaluated or applied in clinical trials for utility. However, the quality, efficiency and
Externí odkaz:
https://doaj.org/article/2f268e10cfdc432aa62ae405fee9db19
Autor:
Juanmei Cao, Yong Qu, Shaojie Zhu, Jinshan Zhan, Yiting Xu, Yifan Jin, Yuqing Wang, Zhuoxia Li, Chuxing Chai, Xiangwei Wu, Meng Gao, Changzheng Huang, Min Li
Publikováno v:
Aggregate, Vol 5, Iss 6, Pp n/a-n/a (2024)
Abstract Photodynamic therapy is a highly recommended alternative treatment for solid tumors, such as cutaneous or luminal tumors, in clinical practice. However, conventional photosensitizers (PSs) often induce undesirable phototoxic effects because
Externí odkaz:
https://doaj.org/article/f4f25c6b19f34caf850bd652ca42fe4b
Autor:
Hiroaki Yamane, Tomoko Itagaki, Keiko Kajitani, Yuji Koura, Yoshiharu Kawabuchi, Masahiro Ohara
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1121-1128 (2023)
Cystoid macular edema (CME) is a rare side effect associated with chemotherapy. Although the development of CME has been reported to occur following treatment with taxane drugs, such as nanoparticle albumin-bound paclitaxel (Nab-PTX), the occurrence
Externí odkaz:
https://doaj.org/article/89e23381732642e28d53c169d2dcc5a4
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Biliary tract cancer (BTC) is a relatively rare but highly aggressive malignancy. However, there is currently no satisfactory second-line regimen for patients without specific genetic mutations. Nanoparticle albumin–bound paclit
Externí odkaz:
https://doaj.org/article/3b3841133de54b5aa701ddfc26ee55f7
Autor:
Zuorun Xie, Junyi Ye, Xinghua Gao, Hang Chen, Maosong Chen, Jiangfang Lian, Jingyun Ma, Hongcai Wang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
Introduction: Glioblastoma (GBM) is a primary brain malignancy with a dismal prognosis and remains incurable at present. In this study, macrophages (MΦ) were developed to carry nanoparticle albumin-bound paclitaxel (nab-PTX) to form nab-PTX/MΦ. The
Externí odkaz:
https://doaj.org/article/e69c94ce71314d459e44d92edfd92c7c
Autor:
Hui Jiang, Qiaoqiao Li, Baoqing Chen, Mian Xi, Kanjiebubi Makelike, Shiliang Liu, Yonghong Hu, Yujia Zhu
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15187-15198 (2023)
Abstract Background This phase I study aimed to assess the safety, dose‐limiting toxicity (DLT), maximum tolerated dose (MTD) and preliminary effect of nanoparticle albumin‐bound (nab)‐paclitaxel in combination with concurrent chemoradiotherapy
Externí odkaz:
https://doaj.org/article/4fe0fa39b65d495c92d2f8902825346e
Autor:
Dao Xin, Yan Song, Lan Mu, Bo Zhang, Ling Qi, Jing Gao, Xingyuan Wang, Jianping Xu, Tao Qu, Jing Huang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 15, Pp 1392-1397 (2023)
Abstract Background There are limited reports on nanoparticle albumin bound‐paclitaxel (nab‐paclitaxel) regimens as second‐ or third‐line treatments for advanced esophageal squamous cell carcinoma (ESCC). Additionally, its safety and efficacy
Externí odkaz:
https://doaj.org/article/f70e0018fafb4473bafc61042dd1b37d
Autor:
Nittiya Suwannasom, Netsai Sriaksorn, Chutamas Thepmalee, Chonthida Thephinlap, Patcharawan Tanamatayarat, Krissana Khoothiam, Hans Bäuemler, Nat Na-Ek
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e21903- (2023)
Background: The efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in advanced non-small cell lung cancer (NSCLC) have yielded inconsistent findings. Materials and methods: We conducted a systematic review and meta-analysis
Externí odkaz:
https://doaj.org/article/3153616375684149a80ba004c188eba3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.